The objective was to investigate the benefits of supplementing enteral feeding with omega-3 fatty acids in children with mild to moderate sepsis and its effects on acute-phase reactants and interleukin 6 (IL-6) level.
Methods:
The study was a prospective randomized, double-blind, placebo-controlled study from January 2012 to June 2014, which included 2 groups of children with mild to moderate sepsis tolerating enteral feeding. Group A included 60 children supplemented with omega-3 fatty acids, whereas group B included 60 children who received enteral feeding without omega-3 supplementation. Both groups had complete blood pictures, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin, and IL-6 before and after 7 days from supplementation.
Results:
There was a significant improvement in hemoglobin percentage (P < .0001), total white blood cell (WBC) count (P < .0001), and platelet count (P < .0001) and significant decrease in CRP (P < .0001), ESR (P < .0001), IL-6 (P < .0001), and albumin level (P < .001) in the supplemented group than the nonsupplemented group. The supplemented group also had a significantly shorter duration of stay in pediatric intensive care unit (PICU; P < .01) and decreased death rate than the nonsupplemented group.
Conclusion:
Children with mild to moderate sepsis showed significant improvement in inflammatory markers and had shorter PICU admission when enteral feeding was supplemented with omega-3 essential fatty acids.
KaurGVinayakNMittalKKaushikJSAamirM. Clinical outcome and predictors of mortality in children with sepsis, severe sepsis, and septic shock from Rohtak, Haryana: a prospective observational study. Indian J Crit Care Med. 2014;18(7):437–441. doi:10.4103/0972-5229.136072.
2.
BryceJBoschi-PintoCShibuyaKBlackRE;WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365(9465):1147–1152. doi:http://dx.doi.org/10.1016/S0140-6736(05)71877-8.
3.
IwashynaTJElyEWSmithDMLangaKM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–1794. doi:10.1001/jama.2010.1553.
4.
BloosFReinhartK. Rapid diagnosis of sepsis. Virulence. 2014;5(1):154–160. doi:10.4161/viru.27393.
5.
FinkMP. The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug?Crit Care Med. 2006;34(3):919–921. doi:10.1097/01.CCM.0000203108.60429.DF.
6.
FiorettoJRMartinJGKurokawaCS. Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine. 2008;43(2):160–164. doi:10.1016/j.cyto.2008.05.005.
7.
RajkumariNMathurPSharmaSGuptaBBhoiSMisraMC. Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study. J Lab Physicians. 2013;5(2):100–108. doi:10.4103/0974-2727.119852.
8.
Abdel-HafezNMSaleh HassanYEl-MetwallyTH. A study on biomarkers, cytokines, and growth factors in children with burn injuries. Ann Burns Fire Disasters. 2007;20(2):89–100.
9.
GrimbleRF. Nutritional modulation of immune function. Proc Nutr Soc. 2001;60(3):389–397.
10.
GultekinGSahinHInancNUyanikFOkE. Impact of omega-3 and omega-9 fatty acids enriched total parenteral nutrition on blood chemistry and inflammatory markers in septic patients. Pak J Med Sci. 2014;30(2):299–304.
11.
GadekJEDeMicheleSJKarlstadMD. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27(8):1409–1420.
12.
Pontes-ArrudaAAragãoAMAlbuquerqueJD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34(9):2325–2333.
13.
GoldsteinBGiroirBRandolphA; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference. definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8. doi:10.1097/01.PCC.0000149131.72248.E6.
14.
JoostenKFHulstJM. Malnutrition in pediatric hospital patients: current issues. Nutrition. 2011;27(2):133–137. doi:10.1016/j.nut.2010.06.001.
15.
KreymannKGBergerMMDeutzNE. DGEM (German Society for Nutritional Medicine), Ebner C, Hartl W, Heymann C, Spies C; ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition. Intensive Care Clin Nutr. 2006;25(2):210–223. doi:10.1016/j.clnu.2006.01.021.
16.
Institute of Medicine of the National Academies. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty acids, Cholesterol, Protein, and Amino Acids. 2005. Washington, DC: The National Academies Press. [online] Available at:http://www.nap.edu/read/10490/chapter/1#ii. Accessed December 16, 2015.
17.
DingYLinYZhuTHuangMXuQ. Interleukin 6 increases dysfunction of organs in sepsis rats through sirtuin 1. Int J Clin Exp Med. 2014;7(9):2593–2598.
18.
SimonLGauvinFAmreDKSaint-LouisPLacroixJ. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217. doi:10.1086/421997.
19.
SchmitXVincentJL. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection. 2008;36:213–219. doi:10.1007/s15010-007-7077-9.
20.
TschaikowskyKHedwig-GeissingMSchmidtJBraunGG. Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant?PLoS One. 2011;6(12):e23615. doi:10.1371/journal.pone.0023615.
21.
WalliullahSMIslamMNSiddikaMHossainMAChowdhuryAK. Role of micro-ESR and I/T ratio in the early diagnosis of neonatal sepsis. Mymensingh Med J. 2009;18(1):56–61.
22.
LinSHuangZWangM. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis. J Crit Care. 2015;30(4):732–738. doi:10.1016/j.jcrc.2015.03.031.
23.
DellingerRPLevyMMRhodesA. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. doi:10.1097/CCM.0b013e31827e83af.
24.
LehmannCSharawiNAl-BannaNCorbettNKuetheJWCaldwellCC. Novel approaches to the development of anti-sepsis drugs. Expert Opin Drug Discov. 2014;9(5):523–531. doi:10.1517/17460441.2014.905538.
25.
Cunningham-RundlesSMcNeeleyDFMoonA. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005;115(6):1119–1128; quiz 1129. doi:10.1016/j.jaci.2005.04.036.
26.
SweeneyBPuriPReenDJ. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int. 2005;21(5):335–340. doi:10.1007/s00383-005-1385-x.
27.
SweeneyBPuriPReenDJ. Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg. 2007;42(4):620–628.
28.
MakrisGCGeroulakosGMakrisMCMikhailidisDPFalagasME. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective. Expert Opin Investig Drugs. 2010;19(7):809–814. doi:10.1517/13543784.2010.490830.
29.
SingerPShapiroHTheillaMAnbarRSingerJCohenJ. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med. 2008;34(9):1580–1592. doi:10.1007/s00134-008-1142-4.
30.
LiangBWangSYeYJ. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol. 2008;14(15):2434–2439. doi:10.3748/wjg.14.2434.
31.
MayerKFegbeutelCHattarK. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003;29(9):1472–1481. doi:10.1007/s00134-003-1900-2.
32.
GultekinGSahinHInancNUyanikFOkE. Impact of omega-3 and omega-9 fatty acids enriched total parenteral nutrition on blood chemistry and inflammatory markers in septic patients. Pak J Med Sci. 2014;30(2):299–304.
33.
BarbosaVMMilesEACalhauCLafuenteECalderPC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care. 2010;14(1):R5. doi:10.1186/cc8844. PMID: 20085628.
34.
Grau-CarmonaTMorán-GarcíaVGarcía-de-LorenzoA. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin Nutr. 2011;30(5):578–584. doi:10.1016/j.clnu.2011.03.004.
35.
HellerARRösslerSLitzRJ. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34(4):972–979. doi:10.1097/01.CCM.0000206309.83570.45.
36.
SingerPTheillaMFisherHGibsteinLGrozovskiECohenJ. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033–1038. doi:10.1097/01.CCM.0000206111.23629.0A.
